CRCM LP position in ARTV
LATIGO BIOTHERAPEUTICS INC · Health Care
CRCM LP reported holding 25,386 shares of ARTV (LATIGO BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$424K, representing 0.24% of its reported portfolio and ranking #15 among its reported holdings. CRCM LP first reported this position in Q3 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How CRCM LP's ARTV position evolved
CRCM LP first disclosed a stake in ARTV in Q3 2026 at 25,386 shares (US$424K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 25.39K | $423.95K | New |
About ARTV and 13F data
ARTV (LATIGO BIOTHERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K sh · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K sh · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K sh · $5.09M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M · Q2 2026
- Revelation Capital Management, LLC 299.31K sh · $2.13M · Q3 2026
- KVP Capital Advisors, LP 200.00K sh · $1.94M · Q2 2026
FAQ
How long has CRCM LP held ARTV?
CRCM LP has disclosed ARTV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is CRCM LP's current position in ARTV?
As of Q3 2026, CRCM LP holds 25.39K shares of ARTV (LATIGO BIOTHERAPEUTICS INC), valued at $423.95K, representing 0.24% of its reported portfolio and ranking #15.
Has CRCM LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), CRCM LP newly opened its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.